USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma-Reference-Cited by-同舟云学术

USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma

Published:2016-06-17 Issue:8 Volume:8 Page:851-862
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Engel Katharina¹,Rudelius Martina²,Slawska Jolanta¹,Jacobs Laura¹,Ahangarian Abhari Behnaz³,Altmann Bettina⁴,Kurutz Julia¹,Rathakrishnan Abirami¹,Fernández‐Sáiz Vanesa¹⁵,Brunner Andrä¹,Targosz Bianca‐Sabrina¹,Loewecke Felicia¹,Gloeckner Christian Johannes⁶⁷,Ueffing Marius⁶,Fulda Simone³⁵,Pfreundschuh Michael⁸,Trümper Lorenz⁹,Klapper Wolfram¹⁰,Keller Ulrich¹⁵,Jost Philipp J¹^ORCID,Rosenwald Andreas²,Peschel Christian¹⁵,Bassermann Florian¹⁵^ORCID

Affiliation:

1. Department of Medicine III Klinikum Rechts der Isar Technische Universität München München Germany

2. Institute of Pathology and Comprehensive Cancer Center Mainfranken Universität Würzburg Würzburg Germany

3. Institut für Experimentelle Tumorforschung in der Pädiatrie Goethe‐Universität Frankfurt Frankfurt am Main Germany

4. Institute for Medical Informatics, Statistics and Epidemiology Universität Leipzig Leipzig Germany

5. German Cancer Consortium (DKTK) German Cancer Research Center (DKFZ) Heidelberg Germany

6. Eberhard‐Karls‐Universität Tübingen Institute for Ophthalmic Research Medical Proteome Center Tübingen Germany

7. German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany

8. Department of Medicine I Saarland University Medical School Homburg (Saar) Germany

9. Department of Hematology and Oncology Georg‐August‐Universität Göttingen Göttingen Germany

10. Institute of Pathology Haematopathology Section and Lymph Node Registry Universitätsklinikum Schleswig‐Holstein Kiel Germany

Funder

Technische Universität München

Fritz Thyssen Stiftung

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

Wilhelm Sander-Stiftung

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201506047

Reference52 articles.

1. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

2. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas

3. The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response Checkpoint

4. The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer

5. Disruption of the PRKCD–FBXO25–HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP9X regulates the proliferation, survival, migration and invasion of gastric cancer cells by stabilizing MTH1;BMC Gastroenterology;2024-07-29

2. Ubiquitin system mutations in neurological diseases;Trends in Biochemical Sciences;2024-07

3. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

4. The mechanism of USP43 in the development of tumor: a literature review;Aging;2024-04-08

5. The Emerging Role of Deubiquitinases in Radiosensitivity;International Journal of Radiation Oncology*Biology*Physics;2023-12